__timestamp | Amgen Inc. | Bristol-Myers Squibb Company |
---|---|---|
Wednesday, January 1, 2014 | 15641000000 | 11947000000 |
Thursday, January 1, 2015 | 17435000000 | 12651000000 |
Friday, January 1, 2016 | 18829000000 | 14481000000 |
Sunday, January 1, 2017 | 18780000000 | 14710000000 |
Monday, January 1, 2018 | 19646000000 | 16014000000 |
Tuesday, January 1, 2019 | 19006000000 | 18067000000 |
Wednesday, January 1, 2020 | 19265000000 | 30745000000 |
Friday, January 1, 2021 | 19525000000 | 36445000000 |
Saturday, January 1, 2022 | 19917000000 | 36022000000 |
Sunday, January 1, 2023 | 19775000000 | 34313000000 |
Monday, January 1, 2024 | 20566000000 | 36351000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding financial performance is crucial. This analysis compares the gross profit trends of two giants: Amgen Inc. and Bristol-Myers Squibb Company, from 2014 to 2023. Over this period, Amgen's gross profit grew steadily, peaking in 2022 with a 27% increase from 2014. Meanwhile, Bristol-Myers Squibb experienced a dramatic surge, especially between 2019 and 2021, where their gross profit nearly tripled, reflecting strategic acquisitions and product launches. By 2023, Bristol-Myers Squibb's gross profit was approximately 74% higher than Amgen's, highlighting their aggressive market expansion. This decade-long comparison underscores the dynamic nature of the pharmaceutical sector, where strategic decisions significantly impact financial outcomes.
Gross Profit Comparison: Eli Lilly and Company and Amgen Inc. Trends
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Bristol-Myers Squibb Company
Gross Profit Trends Compared: Amgen Inc. vs Gilead Sciences, Inc.
Amgen Inc. vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Amgen Inc. or United Therapeutics Corporation
Amgen Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Amgen Inc. and Ligand Pharmaceuticals Incorporated Trends
Amgen Inc. vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited